The use of exhaled nitric oxide monitoring in primary care asthma clinics: A pilot study

Primary Care Respiratory Journal

Volumn 16, Issue 6, 2007, Pages 349-356

  Gruffydd Jones, Kevin ^a,b   Ward, Sabbi ^b   Stonham, Carol ^c   Macfarlane, Tatiana V ^a   Thomas, Mike ^a,c,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Box Surgery ^*  (United Kingdom)

^c Minchinhampton Surgery   (United Kingdom)

^d Cotswold Cottage ^*  (United Kingdom)

Author keywords

Asthma; Exhaled nitric oxide; Monitoring; Primary care

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; EXHALATION; FEASIBILITY STUDY; FEMALE; HEALTH STATUS; HUMAN; INFORMED CONSENT; LUNG FUNCTION; MALE; MEDICAL PERSONNEL; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT MONITORING; PILOT STUDY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RESPIRATORY CARE; SCHOOL CHILD; SPIROMETRY; SYMPTOMATOLOGY;

ADULT; ASTHMA; BIOLOGICAL MARKERS; CHILD; ENGLAND; EXHALATION; FEMALE; HUMANS; LUMINESCENCE; MALE; MIDDLE AGED; NITRIC OXIDE; PILOT PROJECTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; SPIROMETRY;

EID: 37549023864     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2007.00076     Document Type: Article

References (42)

1. Smith NM. The 'Needs of People with Asthma' survey and initial presentation of the data. Asthma J 2000;5:133-6.
2. British Thoracic Society. The Burden of Lung Disease. British Thoracic Society 2002.
3. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-07.
4. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-7.
5. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9:636-42.
6. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J 2003;21:1000-06.
7. International consensus report on the diagnosis and treatment of asthma. Eur Respir J 1992;5:601-41.
8. British Thoracic Society, Scottish Intercollegiate Guideline Network. British Guidelines on the Management of Asthma. Thorax 2003;58:1-94.
9. Global initiative for Asthma (GINA). Asthma management and prevention. NIH Publication No. 96-3659A. 1995. Bethesda, Maryland, NHLBI.
10. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998;101:S427-33.
11. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998;157:S1-S53.
12. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999;159:941-4.
13. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52(suppl 39):1-34.
14. Drake AJ, Howells RJ, Shield JPH, et al. Lesson of the week: Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate * Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult BMJ 2002;324:1081-3.
15. Todd GRD, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-61.
16. Thomas M, Leather D, Price D. High-dose inhaled corticosteroids and add-on therapy use in adults in the UK in 2003: an observational study. Prim Care Resp J 2006;15:166-72. doi:10.1016/j.pcrj.2006.02.009
17. Thomas M, Turner S, Leather D, Price D. High dose inhaled corticosteroid use in childhood asthma: an observational study. Br J Gen Pract 2006;56:788-90.
18. Teeter JG, Bleecker ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998;113:277.
19. Rimington LD, Davies DH, Lowe D, Pearson MG. Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax 2001;56:266-71
20. Thomas M, Grifiths C. Asthma and panic: scope for intervention? Am J Respir Crit Care Med 2005;171:1197-8.
21. Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ 2001;322:1098-100.
22. Taylor D, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006;61:817-27.
23. Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy 2005;35:1175-9.
24. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000;106:638-44.
25. Magnussen H, Hargreave FE. Non-invasive monitoring of airway inflammation. Eur J Respir Dis 2000;16:1-2.
26. Kharitonov S, Gonio F, Kelley C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy asthmatic adults and children. Eur Respir J 2003;21:1-6.
27. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2003;360:1715-21.
28. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical Use of Noninvasive Measurements of Airway Inflammation in Steroid Reduction in Children. Am J Respir Crit Care Med 2005;171:1077-82.
29. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma. N Engl J Med 2005;352:2163-73.
30. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating Steroids on Exhaled Nitric Oxide in Children with Asthma: A Randomized Controlled Trial. Am J Respir Crit Care Med 2005;172:831-6.
31. Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: A predictor of steroid response. Am J Respir Crit Care Med 2005;171:453-9
32. Smith AD, Cowan JO, Filsell S, et al. Diagnosing Asthma- Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests. Am J Respir Crit Care Med 2004;169:473-8.
33. Price D, Wolfe S. Delivery of asthma care: patients' use of and views on healthcare services, as determined from a national interview survey. Asthma J 2000;5:141-4.
34. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004;114:1241-56.
35. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999;160:2117.
36. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of life Questionnaire. Eur Respir J 1999;14:32-8.
37. Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics 1999;16:605-25.
38. Juniper EF, O'Byrne P, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-07.
39. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 1 - correlation within subjects. BMJ 1995;310:446.
40. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 2 - correlation between subjects. BMJ 1995;663:1995.
41. Taylor DR, Pijnenburg MW, Smith AD, Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006;61:917-827.
42. Barnes N. Outcome measures in asthma. Thorax 2000;55(suppl 1):S70-S74.